Table 2 Results obtained by the SIA method and realized by the British Pharmacopoeia method for diclofenac assay in raw materials and pharmaceutical formulations
From: Screening of conditions controlling spectrophotometric sequential injection analysis
Trade name | Formulation | Diclofenac content | Mean recovery ± RSD(%)1 | t2 |
|---|---|---|---|---|
Samf® | Bulk | - | 99.3 ± 1.45 | 2.14 |
OlfenTM-25 | Tablets | 25 mg | 98.5 ± 2.14 | 2.06 |
OlfenTM-50 | Tablets | 50 mg | 98.1 ± 2.81 | 2.11 |
Olfen®-75 I.M. | Injection | 75 mg in 2 ml | 99.1 ± 2.26 | 1.87 |
Voltaren® | Gel | 1% (w/w) | 103.4 ± 3.49 | 2.23 |
Diclogesic® | Gel | 1% (w/w) | 102.7 ± 3.18 | 2.70 |